DCTH Delcath Systems, Inc. - Common Stock
$16,93
Fiyat · Ağu 18, 2026
Temel veriler itibarıyla Ağu 6, 2026
52 Haftlık Aralık
$8–$17
95% of range
Analist Derecelendirmesi
BUY
12 analysts
Fiyat Hedefi
$24
+42% upside
P/E (TTM)
241.9
ROE
2.5%
Net Kâr Marjı
3.2%
Delcath Systems, Inc. - Common Stock Hakkında Wikipedia'dan şirket genel bakışı
Delcath Systems, Inc. is a publicly traded specialty pharmaceutical and medical device company, that develops percutaneous perfusion technologies for the targeted administration of high-dose chemotherapeutic agents to specific organs or regions of the body. Based in Queensbury, New York, the company has an intellectual property portfolio consisting of 28 patents worldwide. Delcath's Percutaneous Hepatic Perfusion (PHP) is currently undergoing Phase II and Phase III trials against tumors in the liver. Delcath has a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute and has received Fast Track and a Special Protocol Assessment from the Food and Drug Administration for its use of melphalan in treating unresectable liver tumors. PHP, also known as the Delcath System, is tested for the treatment of metastatic melanoma in the liver and for primary liver cancer and metastatic hepatic malignancies from neuroendocrine cancers and adenocarcinomas, as well as patients with melanoma who previously received isolated perfusion. Chemotherapy is usually delivered intravenously, although a number of agents can be administered orally.
Devamını oku
Delcath Systems, Inc. (NASDAQ: DCTH) is a publicly traded specialty pharmaceutical and medical device company, that develops percutaneous perfusion technologies for the targeted administration of high-dose chemotherapeutic agents to specific organs or regions of the body. Based in Queensbury, New York, the company has an intellectual property portfolio consisting of 28 patents worldwide. Delcath's Percutaneous Hepatic Perfusion (PHP) is currently undergoing Phase II and Phase III trials against tumors in the liver. Delcath has a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute and has received Fast Track and a Special Protocol Assessment from the Food and Drug Administration for its use of melphalan in treating unresectable liver tumors. PHP, also known as the Delcath System, is tested for the treatment of metastatic melanoma in the liver and for primary liver cancer and metastatic hepatic malignancies from neuroendocrine cancers and adenocarcinomas, as well as patients with melanoma who previously received isolated perfusion. Chemotherapy is usually delivered intravenously, although a number of agents can be administered orally (e.g. specialty drugs, melphalan (trade name Alkeran), busulfan, capecitabine).
## Phase III melanoma trial enrolling
University of Pittsburgh Medical Center
National Cancer Institute in Bethesda, Maryland
Albany Medical Center in Albany, New York
John Wayne Cancer Center in Santa Monica, California
Moffitt Cancer Center in Tampa, Florida
Morristown Memorial Hospital in Morristown, New Jersey
Providence Cancer Center in Portland, Oregon
St. Luke's Cancer Center of Bethlehem, Pennsylvania
Swedish Medical Center in Englewood, Colorado
University of Maryland Medical Center in Baltimore, Maryland
University of Texas Medical Branch in Galveston, Texas
Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
DCTH Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$16.93
Piyasa Değeri
$587M
P/E (TTM)
241.9
EPS (TTM)
$0.07
Gelir (TTM)
$85M
Temettü Verimi
—
ROE
2.5%
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$8 – $17
DCTH Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$85M
2016-12-31
→
2025-12-31
Hisse Başına Kâr
$0.07
2017-12-31
→
2025-12-31
Serbest Nakit Akışı
$21M
2018-12-31
→
2025-12-31
Marjlar
3.2%
2022-12-31
→
2025-12-31
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
DCTH
Akran Ortalaması
P/E (TTM)
241.9
32.9
P/S (TTM) (F/S (TTM))
6.9
4.6
P/B (F/D)
5.3
3.5
Price / FCF (Fiyat / Serbest Nakit Akışı)
28.0
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
DCTH
Akran Ortalaması
Gross Margin (Brüt Kar Marjı)
86.2%
66.5%
Operating Margin (Faaliyet Kâr Marjı)
0.77%
—
Net Profit Margin (Net Kâr Marjı)
3.2%
-9.8%
ROA
2.7%
-8.8%
ROE
2.5%
-15.5%
ROIC
0.46%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
DCTH
Akran Ortalaması
Current Ratio (Cari Oran)
10.9
4.8
Quick Ratio (Cari Oran)
5.0
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
DCTH
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
129.1%
—
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)
215.3%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
DCTH
Akran Ortalaması
DCTH Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
12 analist
- Güçlü Al 3 25,0%
- Al 8 66,7%
- Tut 1 8,3%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
5 analist · 2026-08-18
Medyan
$22.00
Ortalama
$24.00
← Tüm hedeflerin altında
$16.93
Düşük
$21.00
Yüksek
$32.00
Medyan hedef
$22.00
+29,9%
Ortalama hedef
$24.00
+41,8%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
0.05%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 30 Haziran 2026 | $0.07 | $-0.09 | 0.16% |
| 31 Mart 2026 | $-0.03 | $-0.09 | 0.06% |
| 31 Aralık 2025 | $-0.05 | $-0.06 | 0.01% |
| 30 Eylül 2025 | $0.02 | $0.02 | -0.00% |
| 30 Haziran 2025 | $0.07 | $0.03 | 0.04% |
| 31 Mart 2025 | $0.03 | $0.02 | 0.01% |
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| DCTH | $350M | 144.3 | 129.1% | 3.2% | 2.5% | 86.2% |
| BBNX | $1.35B | -16.8 | 53.9% | -73.0% | -24.9% | 55.4% |
| SSII | — | -94.7 | 105.7% | — | — | — |
| ANGO | $479M | -13.0 | 9.5% | -11.5% | -21.2% | 54.6% |
| TCMD | $651M | 35.4 | 12.5% | 5.8% | 9.2% | 75.9% |
| NPCE | $518M | -23.4 | 25.1% | -21.5% | -111.6% | 77.2% |
| VREX | $498M | -7.0 | 4.1% | -8.3% | -14.0% | 34.4% |
| CLPT | $402M | -15.2 | 17.8% | -69.1% | -106.9% | 61.4% |
| SGHT | $424M | -10.7 | -3.1% | -49.7% | -57.4% | 86.2% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 18
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $85M | $37M | $2M | $3M | $4M | · | · | · | $3M | $2M | $2M | $1M | |
| Cost of Revenue | $12M | $6M | $635.0K | $686.0K | $671.0K | $640.0K | $719.0K | $1M | $701.0K | $550.0K | $462.0K | $291.0K | |
| Gross Profit | $73M | $31M | $1M | $2M | $3M | $1M | $861.0K | $2M | $2M | $1M | $1M | $778.0K | |
| R&D Expense | $29M | $14M | $18M | $19M | $14M | $11M | $9M | $20M | $10M | $8M | $6M | $4M | |
| SG&A Expense | $44M | $30M | $22M | $17M | $14M | $11M | $11M | $10M | $10M | $9M | $10M | $16M | |
| Operating Expenses | $73M | $43M | $40M | $36M | $27M | $22M | $21M | $29M | $20M | $18M | $16M | $20M | |
| Operating Income | $660.0K | $-12M | $-38M | $-34M | $-25M | $-21M | $-20M | $-27M | $-18M | $-16M | $-15M | $-19M | |
| Interest Expense | · | · | · | · | · | · | · | · | $22M | $14M | $67.0K | · | |
| Interest Income | · | · | · | · | · | · | · | · | · | $17.0K | $9.0K | $5.0K | |
| Other Non-op | $-70.0K | $-30.0K | $-59.0K | $30.0K | $68.0K | $154.0K | $2.0K | $51.0K | $-41.0K | $17.0K | $9.0K | $-24.0K | |
| Pretax Income | $4M | $-26M | $-48M | $-37M | $-26M | $-24M | $-9M | $-19M | $-45M | $-18M | $-15M | $-17M | |
| Income Tax | $810.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $3M | $-26M | $-48M | $-37M | $-26M | $-24M | $-9M | $-19M | $-45M | $-18M | $-15M | $-17M | |
| EPS (Basic) | $0.08 | $-0.93 | $-2.94 | $-4.12 | $-3.59 | $-8.35 | $-342.83 | $-0.72 | $-3250.00 | · | $-0.91 | $-1.84 | |
| EPS (Diluted) | $0.07 | $-0.93 | $-2.94 | $-4.12 | $-3.59 | $-8.35 | $-342.83 | $-0.72 | $-3250.00 | · | $-0.91 | $-1.84 | |
| Shares (Basic) | 35,821,157 | 28,511,393 | 16,229,931 | 8,864,615 | 7,145,754 | 2,897,827 | 25,900 | 26,705,375 | 14,039 | · | 16,161,687 | 9,452,050 | |
| Shares (Diluted) | 39,919,557 | 28,511,393 | 16,229,931 | 8,864,615 | 7,145,754 | 2,897,827 | 25,900 | 26,705,375 | 14,039 | · | 16,161,687 | 9,452,050 | |
| EBITDA | $660.0K | $-12M | $-38M | $-34M | $-25M | $-21M | $-20M | $-27M | · | · | $-15M | $-19M |
Bilanço 25
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $43M | $32M | $13M | $8M | $23M | $29M | $10M | $3M | $4M | $4M | $13M | $20M | |
| Receivables | $12M | $11M | $241.0K | $366.0K | $44.0K | $57.0K | $21.0K | $585.0K | $317.0K | $403.0K | $277.0K | $174.0K | |
| Inventory | $10M | $7M | $3M | $2M | $1M | $855.0K | $654.0K | $858.0K | $1M | $660.0K | $757.0K | $349.0K | |
| Prepaid Expense | $6M | $3M | $1M | $2M | $3M | $3M | $2M | $898.0K | $700.0K | $698.0K | $960.0K | $974.0K | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $222.0K | |
| Current Assets | $120M | $74M | $37M | $16M | $31M | $32M | $13M | $6M | $8M | $34M | $15M | $22M | |
| PP&E (Net) | $3M | $2M | $1M | $1M | $1M | $1M | $735.0K | $925.0K | $1M | $1M | $1M | $2M | |
| PP&E (Gross) | $8M | $7M | $6M | $6M | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $6M | |
| Accum. Depreciation | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | |
| Total Assets | $124M | $77M | $39M | $18M | $33M | $35M | $14M | $7M | $9M | $35M | $16M | $24M | |
| Accounts Payable | $3M | $961.0K | $1M | $2M | $638.0K | $2M | $5M | $8M | $4M | $594.0K | $284.0K | $748.0K | |
| Accrued Liabilities | $8M | $5M | $5M | $5M | $4M | $5M | $7M | $8M | $3M | $3M | $2M | $4M | |
| Current Liabilities | $11M | $6M | $16M | $15M | $6M | $10M | $16M | $18M | $8M | $36M | $6M | $5M | |
| Capital Leases | $835.0K | $933.0K | $0 | · | $207.0K | $450.0K | $197.0K | $0 | · | · | · | · | |
| Other Non-current Liabilities | $628.0K | $766.0K | $840.0K | $1M | $207.0K | · | $0 | $628.0K | $395.0K | $604.0K | $820.0K | $1M | |
| Total Liabilities | $12M | $8M | $23M | $24M | $21M | $13M | $21M | $22M | $8M | $37M | $7M | $6M | |
| Long-term Debt | · | $0 | $10M | $16M | · | · | · | · | · | · | · | · | |
| Common Stock | $347.0K | $331.0K | $228.0K | $100.0K | $79.0K | $60.0K | $1.0K | $0 | $2.0K | $0 | $14.0K | $97.0K | |
| Paid-in Capital | $639M | $600M | $521M | $452M | $433M | $417M | $365M | $329M | $326M | $278M | $270M | $265M | |
| Retained Earnings | $-529M | $-532M | $-505M | $-457M | $-421M | $-395M | $-371M | $-344M | $-325M | $-279M | $-261M | $-247M | |
| Treasury Stock | · | · | · | · | · | · | · | $0 | $51.0K | $51.0K | $51.0K | $51.0K | |
| AOCI | $575.0K | $82.0K | $135.0K | $-83.0K | $18.0K | $-104.0K | $28.0K | $50.0K | $42.0K | $-41.0K | $-8.0K | $20.0K | |
| Stockholders' Equity | $111M | $69M | $16M | $-6M | $12M | $22M | $-6M | $-15M | $678.0K | $-1M | $9M | $18M | |
| Liabilities + Equity | $124M | $77M | $39M | $18M | $33M | $35M | $14M | $7M | $9M | $35M | $16M | $24M | |
| Shares Outstanding | 34,691,671 | 33,061,002 | 22,761,554 | 10,046,571 | 7,906,728 | 5,996,101 | 67,091 | 14,715 | 228,139 | 11,750 | 1,360,239 | 9,708,841 |
Nakit Akışı 12
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Deferred Tax | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $23M | $-19M | $-31M | $-25M | $-23M | $-23M | $-24M | $-15M | $-15M | $-14M | $-16M | $-16M | |
| CapEx | $2M | $559.0K | $58.0K | $209.0K | $143.0K | $782.0K | $24.0K | $76.0K | $524.0K | $258.0K | $170.0K | $44.0K | |
| Investing Cash Flow | $-27M | $-981.0K | $-20M | $-209.0K | $-143.0K | $-782.0K | $-24.0K | $-76.0K | $-524.0K | · | · | · | |
| Net Debt Issued | · | $-11M | $-6M | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $481.0K | $250.0K | $123.0K | $0 | $2M | $230.0K | $0 | $11M | · | · | · | · | |
| Stock Repurchased | $6M | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $-6M | $250.0K | $123.0K | · | $2M | $230.0K | $0 | · | · | · | · | · | |
| Financing Cash Flow | $15M | $39M | $52M | $10M | $21M | $42M | $30M | $13M | $-11M | · | · | · | |
| Net Change in Cash | $11M | $20M | $874.0K | $-15M | $-2M | $19M | $7M | $-2M | $-26M | $-8M | $-8M | $-11M | |
| Taxes Paid | $2M | $0 | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $21M | $-19M | $-31M | $-25M | $-23M | $-24M | $-24M | $-15M | · | · | $-17M | $-16M |
Kârlılık 8
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 86.2% | 83.4% | 69.2% | 74.8% | · | · | · | · | · | · | 73.6% | 72.8% | |
| Operating Margin | 0.77% | -33.4% | -1849.0% | -1245.0% | · | · | · | · | · | · | -870.6% | -1805.8% | |
| Net Margin | 3.2% | -70.9% | -2308.9% | -1342.7% | · | · | · | · | · | · | -841.7% | -1625.9% | |
| Pretax Margin | 4.1% | -70.9% | -2308.9% | -1342.7% | · | · | · | · | · | · | -841.7% | · | |
| EBITDA Margin | 0.77% | -33.4% | -1849.0% | -1245.0% | · | · | · | · | · | · | -870.6% | -1805.8% | |
| ROA | 2.7% | -45.8% | -168.8% | -143.2% | -75.7% | -98.9% | -84.3% | -244.4% | · | · | -74.5% | -57.1% | |
| ROE | 2.5% | -68.2% | -235.5% | 657.5% | -216.7% | -190.6% | 70.5% | 194.1% | · | · | -109.9% | -72.0% | |
| ROIC | 0.46% | -18.1% | -242.0% | 577.8% | -205.3% | -96.5% | 313.2% | · | · | · | -176.8% | · |
Likidite ve Solventlik 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.9 | 12.0 | 2.3 | 1.1 | 5.2 | 3.2 | 0.8 | 0.3 | · | · | 2.3 | 4.8 | |
| Quick Ratio | 5.0 | 7.0 | 0.8 | 0.5 | 3.8 | 2.9 | 0.6 | 0.2 | · | · | 2.0 | 4.5 |
Verimlilik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.9 | 0.6 | 0.1 | 0.1 | · | · | · | · | · | · | 0.1 | 0.0 | |
| Inventory Turnover | 1.4 | 1.2 | 0.2 | 0.4 | 0.6 | 0.8 | 1.0 | 1.0 | · | · | 0.8 | 0.5 | |
| Receivables Turnover | 7.5 | 6.7 | 6.8 | 13.3 | · | · | · | · | · | · | 7.7 | 4.1 |
Büyüme Oranları 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 129.1% | 1701.7% | -24.1% | -23.5% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 215.3% | 118.7% | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM) 10
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $85M | $37M | $2M | $3M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $1M | |
| Net Income TTM | $3M | $-26M | $-48M | $-37M | $-26M | $-24M | $-9M | $-19M | $-45M | $-18M | $-15M | $-17M | |
| Market Cap | $350M | $398M | $95M | $28M | $61M | $107M | $1M | $2.01B | · | · | · | · | |
| P/E | 144.3 | -12.9 | -1.4 | -0.9 | -2.2 | -2.1 | -0.1 | -272.2 | · | · | · | · | |
| P/S | 4.1 | 10.7 | 45.9 | 10.5 | 17.2 | 34.8 | 0.5 | 649.3 | · | · | · | · | |
| P/B | 3.2 | 5.8 | 6.0 | -4.9 | 5.1 | 4.9 | -0.2 | -134.2 | · | · | · | · | |
| P / Tangible Book | 3.2 | 5.8 | 6.0 | · | 5.1 | 4.9 | · | · | · | · | · | · | |
| P / Cash Flow | 15.6 | -21.3 | -3.0 | -1.1 | -2.7 | -4.7 | -0.1 | -136.1 | · | · | · | · | |
| P / FCF | 16.7 | -20.7 | -3.0 | -1.1 | -2.7 | -4.5 | -0.1 | -135.4 | · | · | · | · | |
| Earnings Yield | 0.69% | -7.7% | -70.7% | -114.4% | -46.3% | -46.6% | -1613.3% | -0.37% | · | · | · | · |
Gelir Tablosu 16
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $29M | $25M | $21M | $21M | $24M | $20M | $15M | $11M | $8M | $3M | $539.0K | $434.0K | $495.0K | $597.0K | $638.0K | $906.0K | |
| Cost of Revenue | $3M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $903.0K | $171.0K | $133.0K | $150.0K | $181.0K | $238.0K | $235.0K | |
| Gross Profit | $26M | $21M | $18M | $18M | $21M | $17M | $13M | $10M | $6M | $2M | $368.0K | $301.0K | $345.0K | $416.0K | $400.0K | $671.0K | |
| R&D Expense | $10M | $10M | $9M | $8M | $7M | $5M | $3M | $4M | $3M | $4M | $5M | $5M | $4M | $5M | $4M | $4M | |
| SG&A Expense | $13M | $13M | $11M | $10M | $11M | $11M | $7M | $7M | $7M | $9M | $7M | $6M | $5M | $4M | $4M | $5M | |
| Operating Expenses | $24M | $23M | $20M | $18M | $18M | $16M | $10M | $11M | $10M | $13M | $12M | $11M | $8M | $9M | $8M | $9M | |
| Operating Income | $2M | $-2M | $-2M | $-388.0K | $3M | $642.0K | $3M | $-1M | $-4M | $-10M | $-11M | $-11M | $-8M | $-8M | $-8M | $-8M | |
| Other Non-op | $-17.0K | $-58.0K | $-7.0K | $-33.0K | $-34.0K | $4.0K | $-53.0K | $35.0K | $10.0K | $-22.0K | $-73.0K | $-5.0K | $6.0K | $13.0K | $27.0K | $26.0K | |
| Pretax Income | $3M | $-908.0K | $-1M | $375.0K | $3M | $1M | $-3M | $2M | $-14M | $-11M | · | · | · | · | · | · | |
| Income Tax | $491.0K | $162.0K | $562.0K | $-455.0K | $508.0K | $195.0K | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Income | $3M | $-1M | $-2M | $830.0K | $3M | $1M | $-3M | $2M | $-14M | $-11M | $-11M | $-20M | $-7M | $-9M | $-8M | $-9M | |
| EPS (Basic) | $0.07 | $-0.03 | $-0.05 | $0.02 | $0.08 | $0.03 | $-0.06 | $0.06 | $-0.48 | $-0.45 | $-0.45 | $-1.14 | $-0.58 | $-0.77 | $-0.82 | $-0.96 | |
| EPS (Diluted) | $0.07 | $-0.03 | $-0.05 | $0.02 | $0.07 | $0.03 | $-0.06 | $0.06 | $-0.48 | $-0.45 | $-0.45 | $-1.14 | $-0.58 | $-0.77 | $-0.82 | $-0.96 | |
| Shares (Basic) | 35,891,915 | 36,021,210 | -70,991,574 | 36,383,277 | 35,786,813 | 34,642,641 | -53,478,825 | 28,738,307 | 28,364,731 | 24,887,180 | -25,719,196 | 17,863,078 | 12,463,665 | 11,622,384 | -16,732,137 | 9,215,786 | |
| Shares (Diluted) | 39,761,480 | 36,021,210 | -79,911,141 | 40,056,814 | 40,262,764 | 39,511,120 | -57,086,190 | 32,345,672 | 28,364,731 | 24,887,180 | -25,719,196 | 17,863,078 | 12,463,665 | 11,622,384 | -16,732,137 | 9,215,786 | |
| EBITDA | $2M | $-2M | · | $-388.0K | $3M | $642.0K | · | $-1M | $-4M | $-10M | · | $-11M | $-8M | $-8M | · | $-8M |
Bilanço 23
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $48M | $41M | $43M | $42M | $34M | $13M | $32M | $8M | $15M | $12M | $13M | $40M | $15M | $24M | $8M | $10M | |
| Receivables | $16M | $14M | $12M | $14M | $16M | $14M | $11M | $7M | $4M | $2M | $241.0K | $205.0K | $127.0K | $458.0K | $366.0K | $537.0K | |
| Inventory | $12M | $10M | $10M | $11M | $11M | $7M | $7M | $7M | $6M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | |
| Prepaid Expense | $7M | $7M | $6M | $7M | $6M | $4M | $3M | $1M | $1M | $1M | $1M | $3M | $2M | $2M | $2M | $2M | |
| Current Assets | $131M | $120M | $120M | $121M | $113M | $84M | $74M | $29M | $31M | $34M | $37M | $46M | $19M | $29M | $16M | $18M | |
| PP&E (Net) | $4M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| PP&E (Gross) | $9M | $9M | $8M | $8M | $8M | $7M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | |
| Accum. Depreciation | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | |
| Total Assets | $137M | $125M | $124M | $124M | $117M | $87M | $77M | $32M | $34M | $36M | $39M | $48M | $21M | $31M | $18M | $20M | |
| Accounts Payable | $4M | $3M | $3M | $2M | $5M | $2M | $961.0K | $937.0K | $3M | $1M | $1M | $753.0K | $966.0K | $2M | $2M | $3M | |
| Accrued Liabilities | $9M | $7M | $8M | $6M | $6M | $4M | $5M | $6M | $4M | $4M | $5M | $5M | $6M | $7M | $5M | $5M | |
| Current Liabilities | $13M | $11M | $11M | $8M | $10M | $5M | $6M | $22M | $12M | $13M | $16M | $14M | $11M | $13M | $15M | $14M | |
| Capital Leases | $2M | $815.0K | $835.0K | $855.0K | $877.0K | $906.0K | $933.0K | $963.0K | $989.0K | $1M | $0 | · | · | · | · | · | |
| Other Non-current Liabilities | $327.0K | $615.0K | $628.0K | $582.0K | $578.0K | $896.0K | $766.0K | $563.0K | $632.0K | $962.0K | $840.0K | $1M | $1M | $1M | $1M | $1M | |
| Total Liabilities | $16M | $12M | $12M | $9M | $12M | $7M | $8M | $23M | $30M | $21M | $23M | $23M | $21M | $25M | $24M | $25M | |
| Long-term Debt | · | · | · | · | · | · | · | $2M | $4M | $7M | $10M | · | · | · | $16M | · | |
| Common Stock | $346.0K | $344.0K | $347.0K | $353.0K | $350.0K | $334.0K | $331.0K | $280.0K | $279.0K | $254.0K | $228.0K | $197.0K | $153.0K | $101.0K | $100.0K | $86.0K | |
| Paid-in Capital | $648M | $642M | $639M | $641M | $632M | $610M | $600M | $536M | $534M | $530M | $521M | $519M | $473M | $453M | $452M | $442M | |
| Retained Earnings | $-527M | $-530M | $-529M | $-527M | $-528M | $-530M | $-532M | $-528M | $-530M | $-516M | $-505M | $-494M | $-474M | $-466M | $-457M | $-447M | |
| AOCI | $258.0K | $571.0K | $575.0K | $875.0K | $592.0K | $381.0K | $82.0K | $11.0K | $8.0K | $157.0K | $135.0K | $-59.0K | $-64.0K | $-64.0K | $-83.0K | $-57.0K | |
| Stockholders' Equity | $121M | $113M | $111M | $115M | $105M | $80M | $69M | $9M | $4M | $15M | $16M | $25M | $-242.0K | $-13M | $-6M | $-5M | |
| Liabilities + Equity | $137M | $125M | $124M | $124M | $117M | $87M | $77M | $32M | $34M | $36M | $39M | $48M | $21M | $31M | $18M | $20M | |
| Shares Outstanding | 34,636,252 | 34,465,087 | 34,691,671 | 35,308,939 | 34,955,974 | 33,436,612 | 33,061,002 | 28,019,599 | 27,931,393 | 25,439,319 | 22,761,554 | 19,688,991 | 15,250,469 | 10,046,571 | 10,046,571 | 8,597,682 |
Nakit Akışı 10
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $6M | $857.0K | $8M | $5M | $7M | $2M | $-1M | $-4M | $-4M | $-10M | $-8M | $-9M | $-10M | $-4M | $-7M | $-5M | |
| CapEx | $503.0K | $570.0K | $550.0K | $459.0K | $398.0K | $140.0K | $229.0K | $216.0K | $101.0K | $13.0K | $19.0K | $-1.0K | $40.0K | $0 | $0 | $68.0K | |
| Investing Cash Flow | $-504.0K | $-571.0K | $-561.0K | $-466.0K | $-415.0K | $-25M | $-15M | $-697.0K | $10M | $5M | $-20M | $1.0K | $-40.0K | $0 | $0 | $-68.0K | |
| Stock Issued | $0 | $389.0K | $0 | $243.0K | $0 | $238.0K | $0 | $175.0K | $0 | $75.0K | $0 | $76.0K | $0 | $47.0K | $0 | $0 | |
| Stock Repurchased | $11.0K | $3M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $-3M | · | · | · | $238.0K | · | · | · | $75.0K | · | · | · | $47.0K | · | · | |
| Financing Cash Flow | $962.0K | $-2M | $-6M | $3M | $15M | $3M | $40M | $-2M | $-3M | $4M | $1.0K | $35M | $7.0K | $17M | $5M | $5M | |
| Net Change in Cash | $6M | $-2M | $2M | $7M | $22M | $-20M | $24M | $-6M | $3M | $-886.0K | $-28M | $26M | $-10M | $12M | $-2M | $-372.0K | |
| Taxes Paid | · | · | $228.0K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $287.0K | · | · | · | $2M | · | · | · | $-10M | · | · | · | $-4M | · | · |
Kârlılık 8
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 89.8% | 85.0% | · | 87.2% | 86.3% | 85.6% | · | 85.4% | 80.4% | 71.2% | · | 69.3% | 69.7% | 69.7% | · | · | |
| Operating Margin | 8.2% | -6.6% | · | -1.9% | 10.7% | 3.2% | · | -11.2% | -50.4% | -327.4% | · | -2432.3% | -1615.6% | -1394.5% | · | · | |
| Net Margin | 9.2% | -4.3% | · | 4.0% | 11.2% | 5.4% | · | 16.6% | -176.9% | -354.0% | · | -4686.6% | -1455.0% | -1507.5% | · | · | |
| Pretax Margin | 10.8% | -3.6% | · | 1.8% | 13.3% | 6.4% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | 8.2% | -6.6% | · | -1.9% | 10.7% | 3.2% | · | -11.2% | -50.4% | -327.4% | · | -2432.3% | -1615.6% | -1394.5% | · | · | |
| ROA | 2.1% | -1.0% | · | 1.1% | 3.6% | 1.7% | · | 4.7% | -50.0% | -33.3% | · | -60.0% | -34.2% | -31.1% | · | -31.1% | |
| ROE | 2.4% | -1.1% | · | 1.4% | 4.9% | 2.2% | · | 11.2% | -695.8% | -1439.2% | · | -208.9% | 466.5% | 229.3% | · | -262.5% | |
| ROIC | 1.7% | -1.7% | · | -0.75% | 2.1% | 0.68% | · | · | · | · | · | · | · | · | · | · |
Likidite ve Solventlik 2
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.8 | 11.2 | · | 15.1 | 10.9 | 16.0 | · | 1.3 | 2.6 | 2.5 | · | 3.3 | 1.8 | 2.2 | · | 1.3 | |
| Quick Ratio | 4.8 | 5.2 | · | 6.9 | 4.8 | 5.1 | · | 0.7 | 1.5 | 1.0 | · | 2.9 | 1.3 | 1.8 | · | 0.7 |
Verimlilik 3
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | · | |
| Inventory Turnover | 0.3 | 0.4 | · | 0.3 | 0.4 | 0.5 | · | 0.4 | 0.3 | 0.3 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 1.8 | 1.8 | · | 2.0 | 2.5 | 2.6 | · | 3.1 | 4.0 | 3.1 | · | 1.2 | 1.8 | 1.9 | · | · |
Değerleme (TTM) 10
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $99M | $89M | · | $76M | $63M | $42M | · | $23M | $12M | $5M | · | $2M | $3M | $3M | · | · | |
| Net Income TTM | $5M | $4M | · | $6M | $-8M | $-22M | · | $-43M | $-52M | $-48M | · | $-45M | $-35M | $-37M | · | $-35M | |
| Market Cap | $436M | $320M | · | $380M | $475M | $426M | · | $253M | $234M | $121M | · | $80M | $89M | $58M | · | $28M | |
| P/E | 96.8 | 103.1 | · | 59.7 | -42.5 | -15.2 | · | -4.5 | -3.2 | -1.6 | · | -1.2 | -1.6 | -1.4 | · | -0.8 | |
| P/S | 4.4 | 3.6 | · | 5.0 | 7.6 | 10.2 | · | 11.2 | 19.8 | 26.0 | · | 32.8 | 31.8 | 21.6 | · | · | |
| P/B | 3.6 | 2.8 | · | 3.3 | 4.5 | 5.3 | · | 29.5 | 55.8 | 8.3 | · | 3.2 | -367.4 | -4.4 | · | -5.2 | |
| P / Tangible Book | 3.6 | 2.8 | · | 3.3 | 4.5 | 5.3 | · | 29.5 | 55.8 | 8.3 | · | 3.2 | · | · | · | · | |
| P / Cash Flow | · | 373.2 | · | · | · | 193.2 | · | · | · | -12.7 | · | · | · | -13.5 | · | · | |
| P / FCF | · | 1114.4 | · | · | · | 206.3 | · | · | · | -12.6 | · | · | · | -13.5 | · | · | |
| Earnings Yield | 1.0% | 0.97% | · | 1.7% | -2.4% | -6.6% | · | -22.3% | -31.7% | -61.6% | · | -85.2% | -60.9% | -70.8% | · | -132.5% |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $85M | $37M | $2M | $3M | $4M |
| Brüt Kâr Marjı % | 86.2% | 83.4% | 69.2% | 74.8% | — |
| Faaliyet Kâr Marjı % | 0.77% | -33.4% | -1849.0% | -1245.0% | — |
| Net Gelir | $3M | $-26M | $-48M | $-37M | $-26M |
| Seyreltilmiş Hisse Başı Kâr | $0.07 | $-0.93 | $-2.94 | $-4.12 | $-3.59 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Cari Oran | 10.9 | 12.0 | 2.3 | 1.1 | 5.2 |
| Cari Oran | 5.0 | 7.0 | 0.8 | 0.5 | 3.8 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $21M | $-19M | $-31M | $-25M | $-23M |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 140 dosya · $188.2M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 27 (0 önceki Ç'ye göre) | 17 (-3 önceki Ç'ye göre) | 40 (+6 önceki Ç'ye göre) | 30 (-7 önceki Ç'ye göre) | +1.7M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| Rosalind Advisors, Inc. | $41.551.898 | 3.300.389 | 22,08% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $15.375.500 | 1.221.247 | 8,17% | Hisse senetleri |
| VANGUARD GROUP INC | $14.879.573 | 1.473.225 | 7,91% | Hisse senetleri |
| Propel Bio Management, LLC | $10.971.681 | 871.460 | 5,83% | Hisse senetleri |
| STATE STREET CORP | $8.552.135 | 679.280 | 4,55% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $7.923.535 | 629.139 | 4,21% | Hisse senetleri |
| ALGERT GLOBAL LLC | $7.311.114 | 580.708 | 3,89% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $7.130.611 | 566.371 | 3,79% | Hisse senetleri |
| Divisadero Street Capital Management, LP | $6.292.432 | 499.796 | 3,34% | Hisse senetleri |
| ExodusPoint Capital Management, LP | $4.530.940 | 359.884 | 2,41% | Hisse senetleri |
| Private Wealth Advisors, LLC | $3.913.765 | 310.863 | 2,08% | Hisse senetleri |
| Simplify Asset Management Inc. | $3.333.454 | 264.770 | 1,77% | Hisse senetleri |
| BlackRock, Inc. | $3.180.738 | 252.640 | 1,69% | Hisse senetleri |
| ADAR1 Capital Management, LLC | $2.825.007 | 224.385 | 1,50% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $2.570.450 | 204.166 | 1,37% | Hisse senetleri |
| KENNEDY CAPITAL MANAGEMENT LLC | $2.570.160 | 204.143 | 1,37% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.435.510 | 193.448 | 1,29% | Hisse senetleri |
| Ikarian Capital, LLC | $2.337.548 | 185.667 | 1,24% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $2.290.159 | 181.903 | 1,22% | Hisse senetleri |
| CIBC WORLD MARKET INC. | $2.054.789 | 163.208 | 1,09% | Hisse senetleri |
| Caption Management, LLC | $1.894.795 | 150.500 | 1,01% | Satım opsiyonu |
| GOLDMAN SACHS GROUP INC | $1.885.353 | 149.750 | 1,00% | Hisse senetleri |
| Lane Generational LLC | $1.884.257 | 149.663 | 1,00% | Hisse senetleri |
| HSBC HOLDINGS PLC | $1.705.848 | 135.600 | 0,91% | Hisse senetleri |
| Man Group plc | $1.617.752 | 128.495 | 0,86% | Hisse senetleri |
| Cubist Systematic Strategies, LLC | $1.562.514 | 145.350 | 0,83% | Hisse senetleri |
| Diametric Capital, LP | $1.546.568 | 122.841 | 0,82% | Hisse senetleri |
| MORGAN STANLEY | $1.366.506 | 108.539 | 0,73% | Hisse senetleri |
| BARCLAYS PLC | $1.354.243 | 107.565 | 0,72% | Hisse senetleri |
| Caption Management, LLC | $1.259.000 | 100.000 | 0,67% | Alım opsiyonu |
| Capital Advisors Wealth Management, LLC | $1.170.870 | 93.000 | 0,62% | Hisse senetleri |
| Jefferies Financial Group Inc. | $1.057.308 | 83.980 | 0,56% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.050.824 | 83.465 | 0,56% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.022.308 | 81.200 | 0,54% | Alım opsiyonu |
| Stonepine Capital Management, LLC | $1.000.000 | 100.000 | 0,53% | Alım opsiyonu |
| Caption Management, LLC | $978.243 | 77.700 | 0,52% | Hisse senetleri |
| FOX RUN MANAGEMENT, L.L.C. | $776.526 | 61.678 | 0,41% | Hisse senetleri |
| Quantbot Technologies LP | $749.860 | 59.560 | 0,40% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $728.885 | 57.894 | 0,39% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $725.864 | 57.654 | 0,39% | Hisse senetleri |
| Pale Fire Capital SE | $504.670 | 40.085 | 0,27% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $493.931 | 39.232 | 0,26% | Hisse senetleri |
| WOLVERINE TRADING, LLC | $479.600 | 44.000 | 0,25% | Alım opsiyonu |
| RHUMBLINE ADVISERS | $458.822 | 36.444 | 0,24% | Hisse senetleri |
| ALPS ADVISORS INC | $441.154 | 35.040 | 0,23% | Hisse senetleri |
| EntryPoint Capital, LLC | $437.641 | 34.761 | 0,23% | Hisse senetleri |
| SEI INVESTMENTS CO | $394.936 | 31.369 | 0,21% | Hisse senetleri |
| AMERICAN CENTURY COMPANIES INC | $378.380 | 30.054 | 0,20% | Hisse senetleri |
| Balyasny Asset Management L.P. | $358.412 | 28.468 | 0,19% | Hisse senetleri |
| Leonteq Securities AG | $348.730 | 27.699 | 0,19% | Hisse senetleri |
| CITADEL ADVISORS LLC | $334.894 | 26.600 | 0,18% | Alım opsiyonu |
| BOOTHBAY FUND MANAGEMENT, LLC | $319.484 | 25.376 | 0,17% | Hisse senetleri |
| Xcelsior Advisor Partners LLC | $318.527 | 25.300 | 0,17% | Hisse senetleri |
| Palisades Investment Partners, LLC | $293.007 | 23.273 | 0,16% | Hisse senetleri |
| WOLVERINE TRADING, LLC | $269.666 | 24.740 | 0,14% | Hisse senetleri |
| ALLIANCEBERNSTEIN L.P. | $239.424 | 25.800 | 0,13% | Hisse senetleri |
| MetLife Investment Management, LLC | $235.043 | 18.669 | 0,12% | Hisse senetleri |
| Bank of New York Mellon Corp | $234.942 | 18.661 | 0,12% | Hisse senetleri |
| WealthPlan Investment Management, LLC | $219.607 | 17.443 | 0,12% | Hisse senetleri |
| NOMURA HOLDINGS INC | $210.530 | 16.722 | 0,11% | Hisse senetleri |
| WOLVERINE TRADING, LLC | $209.280 | 19.200 | 0,11% | Satım opsiyonu |
| CITADEL ADVISORS LLC | $202.699 | 16.100 | 0,11% | Satım opsiyonu |
| CITADEL ADVISORS LLC | $189.391 | 15.043 | 0,10% | Hisse senetleri |
| SkyOak Wealth, LLC | $188.850 | 15.000 | 0,10% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $188.850 | 15.000 | 0,10% | Satım opsiyonu |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $166.729 | 13.243 | 0,09% | Hisse senetleri |
| TUDOR INVESTMENT CORP ET AL | $151.609 | 12.042 | 0,08% | Hisse senetleri |
| LANARK FINANCIAL, INC. | $150.500 | 11.954 | 0,08% | Hisse senetleri |
| CITIGROUP INC | $146.485 | 11.635 | 0,08% | Hisse senetleri |
| Invesco Ltd. | $143.790 | 11.421 | 0,08% | Hisse senetleri |
| MERCER GLOBAL ADVISORS INC /ADV | $140.744 | 11.179 | 0,07% | Hisse senetleri |
| Nuveen, LLC | $138.754 | 11.021 | 0,07% | Hisse senetleri |
| Vanguard Global Advisers, LLC | $133.869 | 10.633 | 0,07% | Hisse senetleri |
| Schonfeld Strategic Advisors LLC | $131.136 | 10.416 | 0,07% | Hisse senetleri |
| LPL Financial LLC | $128.859 | 10.235 | 0,07% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $126.580 | 10.054 | 0,07% | Hisse senetleri |
| Police & Firemen's Retirement System of New Jersey | $110.729 | 8.795 | 0,06% | Hisse senetleri |
| SHERBROOKE PARK ADVISERS LLC | $109.918 | 10.883 | 0,06% | Hisse senetleri |
| Hunting Hill Global Capital, LLC | $104.716 | 11.284 | 0,06% | Hisse senetleri |
| MARSHALL WACE, LLP | $84.177 | 6.686 | 0,04% | Hisse senetleri |
| FMR LLC | $69.144 | 5.492 | 0,04% | Hisse senetleri |
| Private Wealth Advisors, LLC | $62.950 | 5.000 | 0,03% | Alım opsiyonu |
| NEW YORK STATE COMMON RETIREMENT FUND | $60.432 | 4.800 | 0,03% | Hisse senetleri |
| OSAIC HOLDINGS, INC. | $60.254 | 4.786 | 0,03% | Hisse senetleri |
| Point72 (DIFC) Ltd | $53.931 | 5.017 | 0,03% | Hisse senetleri |
| NORTHERN TRUST CORP | $53.797 | 4.273 | 0,03% | Hisse senetleri |
| Persistent Asset Partners Ltd | $52.954 | 4.206 | 0,03% | Hisse senetleri |
| Arax Advisory Partners | $51.884 | 4.121 | 0,03% | Hisse senetleri |
| IFP Advisors, Inc | $51.657 | 4.103 | 0,03% | Hisse senetleri |
| Integrated Wealth Concepts LLC | $48.145 | 3.824 | 0,03% | Hisse senetleri |
| Ameritas Investment Partners, Inc. | $38.714 | 3.075 | 0,02% | Hisse senetleri |
| Legal & General Group Plc | $34.534 | 2.743 | 0,02% | Hisse senetleri |
| CWM, LLC | $29.343 | 3.162 | 0,02% | Hisse senetleri |
| Creative Planning | $17.777 | 1.412 | 0,01% | Hisse senetleri |
| Tripletail Wealth Management, LLC | $16.632 | 1.260 | 0,01% | Hisse senetleri |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $14.950 | 1.611 | 0,01% | Hisse senetleri |
| AlphaQuest LLC | $14.473 | 1.433 | 0,01% | Hisse senetleri |
| Tower Research Capital LLC (TRC) | $13.711 | 1.089 | 0,01% | Hisse senetleri |
| Activest Wealth Management | $12.590 | 1.000 | 0,01% | Hisse senetleri |
| Geneos Wealth Management Inc. | $11.621 | 923 | 0,01% | Hisse senetleri |
Şirket yöneticileri 46 içeriden öğrenenler · 11 yöneticiler · 16 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Jennifer K. Simpson | President and CEO | 08 Mayıs 2020 C | 25.021 | 0 | 0 | $0 |
| Barbra Keck | Chief Financial Officer, Secretary | 08 Mayıs 2020 C | 12.851 | 0 | 0 | $0 |
| Paul M Feinstein | Chief Financial Officer | 30 Kasım 2007 A | 3.375 | 0 | 0 | $0 |
| John Purpura | Chief Operating Officer | 13 Ekim 2023 P | 41.526 | 0 | 0 | $0 |
| HERSCHKOWITZ SAMUEL /FA/ | Chief Operating Officer | 29 Mayıs 2007 P | 160.375 | 0 | 0 | $0 |
| Vojo Vukovic | Chief Medical Officer | 12 Aralık 2023 P | 100.000 | 0 | 0 | $0 |
| Sandra Pennell | SVP of Finance, PFO and PAO | 17 Kasım 2023 P | 30.000 | 0 | 0 | $0 |
| David L. Hoffman | General Counsel, Chief Compliance Officer and Secretary | 16 Kasım 2023 P | 40.000 | 0 | 0 | $0 |
| Kevin Muir | Vice President Commercial Operations | 12 Haziran 2023 A | — | 0 | 0 | $0 |
| Johnny John | Senior Vice President Clinical Development and Medical Affairs | 12 Haziran 2023 A | — | 0 | 0 | $0 |
| Christine Padula | Interim Principal Accounting Officer | 01 Eylül 2021 A | — | 0 | 0 | $0 |
| John Richard Sylvester | Yönetim kurulu üyesi | 21 Ağustos 2023 P | 10.550 | 0 | 0 | $0 |
| Aharon Gil | Yönetim kurulu üyesi | 12 Haziran 2023 A | 404.000 | 0 | 0 | $0 |
| Steven A J Salamon | Yönetim kurulu üyesi | 12 Haziran 2023 A | 440.100 | 0 | 0 | $0 |
| Roger G Stoll PHD | Yönetim kurulu üyesi | 12 Haziran 2023 A | 9.309 | 0 | 0 | $0 |
| Rosalind Advisors, Inc. | Yönetim kurulu üyesi | 19 Nisan 2022 P | 433.100 | 0 | 0 | $0 |
| Marco Taglietti | Yönetim kurulu üyesi | 08 Mayıs 2020 C | 6.000 | 0 | 0 | $0 |
| William Dodge Rueckert | Yönetim kurulu üyesi | 08 Mayıs 2020 C | 6.014 | 0 | 0 | $0 |
| Simon Pedder | Yönetim kurulu üyesi | 01 Şubat 2019 A | — | 0 | 0 | $0 |
| Laura A Philips | Yönetim kurulu üyesi | 23 Temmuz 2015 P | 205.299 | 0 | 0 | $0 |
| Harold S Koplewicz | Yönetim kurulu üyesi | 10 Haziran 2015 A | 45.052 | 0 | 0 | $0 |
| Dennis Langer | Yönetim kurulu üyesi | 10 Haziran 2015 A | 20.000 | 0 | 0 | $0 |
| Jonathan Lewis | Yönetim kurulu üyesi | 30 Haziran 2008 A | 10.000 | 0 | 0 | $0 |
| Mark Corigliano | Yönetim kurulu üyesi | 16 Nisan 2007 M | 198.176 | 0 | 0 | $0 |
| Daniel Isdaner | Yönetim kurulu üyesi | 16 Nisan 2007 M | 253.668 | 0 | 0 | $0 |
| Elizabeth Czerepak | — | 13 Mayıs 2026 A | — | 0 | 0 | $0 |
| Gerard J Michel | — | 02 Mart 2026 P | 342.034 | 2 | 0 | $198.447 |
| Laura Brege | — | 07 Temmuz 2014 A | 11.678 | 0 | 0 | $0 |
| Tasos Konidaris | — | 07 Temmuz 2014 A | 11.678 | 0 | 0 | $0 |
| Gabriel Leung | — | 07 Temmuz 2014 A | 21.485 | 0 | 0 | $0 |
| Douglas G Watson | — | 07 Temmuz 2014 A | 136.664 | 0 | 0 | $0 |
| Graham G Miao | — | 14 Kasım 2013 A | 54.000 | 0 | 0 | $0 |
| Peter J Graham | — | 14 Kasım 2013 A | 15.000 | 0 | 0 | $0 |
| William M Appling | — | 15 Temmuz 2013 A | — | 0 | 0 | $0 |
| Krishna Kandarpa | — | 11 Mart 2013 A | 159.000 | 0 | 0 | $0 |
| Harold Mapes | — | 11 Mart 2013 A | 17.000 | 0 | 0 | $0 |
| Eamonn P Hobbs | — | 11 Mart 2013 A | 162.000 | 0 | 0 | $0 |
| Agustin V Gago | — | 11 Mart 2013 A | 80.944 | 0 | 0 | $0 |
| Robert Ladd | — | 15 Haziran 2012 A | 69.534 | 0 | 0 | $0 |
| David Mcdonald | — | 10 Mart 2011 A | 47.706 | 0 | 0 | $0 |
| Pamela Reilly Contag | — | 01 Aralık 2010 A | 8.507 | 0 | 0 | $0 |
| Richard Taney | — | 10 Aralık 2009 A | 211.485 | 0 | 0 | $0 |
| Jason Andrew Rifkin | — | 12 Ekim 2009 A | — | 0 | 0 | $0 |
| KOLY M S /FA/ | — | 26 Ocak 2007 X | 775.360 | 0 | 0 | $0 |
| Victor Nevins | — | 12 Ekim 2006 M | 180.007 | 0 | 0 | $0 |
| VENKOL TRUST | — | 10 Kasım 2004 J | 892.649 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 17 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Rosalind Advisors, Inc., SALAMON STEVEN A J, Aharon Gil, Rosalind Master Fund L.P., Rosalind Opportunities Fund I L.P. ×15 başvurular | 10 Şubat 2026 | 9,90% | Değişiklik | — | SEC |
| Açıklanmayan raporlama kişisi | 16 Aralık 2022 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi | 27 Temmuz 2022 | — | İlk başvuru | — | SEC |
| Laddcap Value Partners LP S.S. or, Laddcap Value Associates LLC S.S. or, Laddcap Value Advisors LLC S.S. or, Robert Ladd S.S. or ×2 başvurular | 02 Ağustos 2010 | — | İlk başvuru | — | SEC |
| Robert Ladd | 18 Ekim 2006 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi | 28 Temmuz 2006 | — | İlk başvuru | Yönetim kurulu kampanyası | SEC |
| Açıklanmayan raporlama kişisi | 11 Temmuz 2006 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi | 14 Haziran 2006 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi | 08 Haziran 2006 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi | 24 Mayıs 2006 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi | 28 Nisan 2006 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi | 10 Ocak 2006 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi | 06 Ocak 2006 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi | 14 Aralık 2005 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi | 10 Kasım 2005 | — | İlk başvuru | Yönetim kurulu kampanyası | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF sahipliği 22 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| SBIO · ALPS ETF Trust | 0,24% | 35.814 NS | 31 Mayıs 2026 | N-PORT |
| IWC · iShares Trust | 0,10% | 97.850 SH | 08 Ağustos 2026 | Günlük |
| GSSC · Goldman Sachs ETF Trust | 0,04% | 35.321 NS | 31 Mayıs 2026 | N-PORT |
| IWN · iShares Trust | 0,02% | 227.534 SH | 08 Ağustos 2026 | Günlük |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 21.358 SH | 08 Ağustos 2026 | Günlük |
| IWM · iShares Trust | 0,01% | 741.852 SH | 08 Ağustos 2026 | Günlük |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,01% | 2.388 SH | 08 Ağustos 2026 | Günlük |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 165.177 SH | 08 Ağustos 2026 | Günlük |
| RSSL · Global X Funds | 0,01% | 13.080 NS | 30 Nisan 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,01% | 22.609 NS | 31 Mayıs 2026 | N-PORT |
| ITWO · ProShares Trust | 0,01% | 1.420 NS | 31 Mayıs 2026 | N-PORT |
| UWM · ProShares Trust | 0,00% | 1.111 NS | 31 Mayıs 2026 | N-PORT |
| IWO · iShares Trust | 0,00% | 38.572 SH | 08 Ağustos 2026 | Günlük |
| URTY · ProShares Trust | 0,00% | 1.122 NS | 31 Mayıs 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 1.638 NS | 31 Mayıs 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 28 NS | 31 Mayıs 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 19.222 NS | 30 Nisan 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 43.750 SH | 08 Ağustos 2026 | Günlük |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 304.809 SH | 08 Ağustos 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 889.410 SH | 08 Ağustos 2026 | Günlük |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 4.438 SH | 08 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2.475 SH | 08 Ağustos 2026 | Günlük |